1 job vacancy at RMT - Legal and Policy Secretary

 

The Morning Star Shop - Online now

 

Donate to the Morning Star Fighting Fund

Subscribe to the Morning Star Mailing List

Progressive Web Listings

Read about EDM 1334

 

 

The Morning Star on Twitter Friends of the Morning Star on Facebook

 

Ken Gill Memorial Fund

 

Revolting Europe - London-based writer, journalist and regular Morning Star contributor Tom Gill focuses on developments in the European left, trade union and social movements

 



 

It's sickening that new vaccine isn't free for all

Tuesday 29 January 2013

At last, a vaccine has been developed and licensed that could help eliminate the deadly disease meningitis B, which in bacterial form kills 200 people a year in Britain.

Unfortunately, the cost "could prevent its being made swiftly available through the national vaccination programme," according to a recent newspaper article.

One wonders how much profit the shareholders of manufacturers Novartis will be demanding to save so many lives?

How much will the government be prepared to pay?

If we can afford billions to upgrade the strategically useless Trident weapons system, which won't save a single life, we should be able to afford Novartis's blood money.

There's no problem for the rich, however, as the vaccine will be available to buy privately as soon as it's launched.

There is something very, very wrong about a society which collectively educates scientists to develop such wonderful products, which are then immediately available only to a rich minority.

John Marais

Cambridge

If you appreciated this article then please consider donating to the Morning Star's Fighting Fund to ensure we can keep developing your paper.

Donate to the Fighting Fund here